Proton Pump Inhibitors Prevent Gastric Antral Ulcers Induced by NSAIDs Via Activation of Capsaicin-Sensitive Afferent Nerves in Mice
Overview
Affiliations
Background/aims: We examined the effects of proton pump inhibitors (PPIs) on gastric antral ulcers induced by non-steroidal anti-inflammatory drugs in re-fed mice and the role of capsaicin-sensitive afferent nerves (CSANs) in the protective effects of PPIs on the antral mucosa.
Methods: Male mice were administered indomethacin after 2 h of re-feeding of diet after a 24-h fast, and gastric lesions were examined 24 h after indomethacin dosing. The effects of PPIs (lansoprazole and omeprazole), histamine H-receptor antagonists (H-RAs, famotidine, ranitidine), capsaicin and misoprostol on the formation of antral ulcers induced by indomethacin were examined. Functional ablation of CSANs was caused by pretreatment of mice with a high dose of capsaicin.
Results: Indomethacin produced lesions selectively in the gastric antrum in re-fed conditions. Formation of antral ulcers was not affected by H-RAs, but inhibited by PPIs, capsaicin and misoprostol. The anti-ulcer effect of lansoprazole was 30 times stronger than that of omeprazole. Antral ulcers induced by indomethacin were markedly aggravated in mice with ablated CSANs. The effects of PPIs and capsaicin on ulcer formation were inhibited by ablation of CSANs, pretreatment with a capsaicin receptor antagonist (capsazepine/ruthenium red) and an inhibitor of nitric oxide synthesis (L-NAME). However, the inhibitory effect of misoprostol was not prevented by the ablation of CSANs or drugs.
Conclusions: The results suggested that CSANs play an important role in protection of the antral mucosa and that both lansoprazole and omeprazole are capable of preventing NSAID-induced antral ulcers by activating CSANs.
Satoh H, Akiba Y, Urushidani T, Kaunitz J Dig Dis Sci. 2024; 69(4):1156-1168.
PMID: 38448762 DOI: 10.1007/s10620-024-08352-6.
Tsunoda C, Hasegawa K, Hiroshige R, Kasai T, Yokoyama H, Goto S Mol Pharm. 2023; 20(10):5032-5042.
PMID: 37688787 PMC: 10548472. DOI: 10.1021/acs.molpharmaceut.3c00291.
Satoh H, Akiba Y, Urushidani T, Kaunitz J Dig Dis Sci. 2023; 68(10):3886-3901.
PMID: 37632663 DOI: 10.1007/s10620-023-08086-x.